As reported by Cattrini et al. [40], AXL was significantly correlated with BTLA, CD244, CD274, CTLA4 and other immune checkpoint molecules in ccRCC, indicating the vital roles of AXL in immunotherapy. Here, CD274 is linked to nonpapillary renal cell carcinoma.